For questions regarding claiming CME Credit, please refer to our FAQ section.
This program will look at the correct timing and modality of transition from intravenous to oral platelet inhibition in patients. Lessons learned from the PHOENIX and CHAMPION study and the outcomes of establishing potent P2Y12 inhibition with medication will be discussed. Prevention of intra-procedural stent thrombosis and the advances of therapies will be reviewed. read more...
Click here to access this CME Program
Watch and listen to four experts in the field of cardiology discuss the future of low risk TAVR procedures. Explore the changes to TAVR through the eyes of surgeons and interventionalists. And learn about the new criteria for TAVR use in patients, including STS scores, frailty, and disability for enrollment in a low risk trial. read more...
Click here to access this CME Program
During this webcast, experts in the field discuss results from the latest data from stent trials and how it guides current practice, as well as the future of the next generation DES. Participants will learn how the new design of DES has changed the landscape and how it benefits patients and how the new devices impact DAPT and patient outcomes. read more...
Click here to access this CME Program
In this webcast, Dr. Vinod Thourani, Dr. Howard Herrmann, and Dr. Michael Reardon discuss the latest findings on the expanded indications of transcatheter aortic valve replacement (TAVR) in intermediate risk and high risk patients, the implications for patient care, and insights into what this means for referring cardiologists. The panel also discusses their firsthand experience with TAVR and the benefits of the Heart Team. read more...
Click here to access this CME Program